You are here: Industry Insights > Clinical Trial

News List

Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate expresspharma
August 25, 2020
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age.
Ampio Provides Update on COVID-19 Clinical Trial Activities prnewswire
August 20, 2020
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials.
Neuroptika Completes Enrollment of Phase 2 Clinical Trial for Dry Eye Disease americanpharmaceuticalreview
August 20, 2020
Neuroptika announced completion of enrollment in a Phase 2 clinical controlled, double-masked trial of NRO-1 for the treatment of patients with dry eye disease.
Pakistan to conduct phase-III clinical trial of COVID-19 vaccine from CanSinoBio expresspharma
August 19, 2020
The NIH said this would be the first-ever phase-III clinical trial for any vaccine in Pakistan.
Kineta Receives Regulatory Approval for Initiation of KCP506 Trial americanpharmaceuticalreview
August 18, 2020
Kineta announced the Clinical Trial Application (CTA) approval in the Netherlands for initiation of a first in-human clinical trial of KCP506. KCP506 is a first-in-class α9α10 nicotinic acetylcholine receptor (nAChR) antagonist in development for the ...
Kaiser Permanente Joins Late-Stage COVID-19 Vaccine Study americanpharmaceuticalreview
August 18, 2020
Kaiser Permanente has begun participating in a phase 3 clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the current COVID-19 global pandemic.
Zydus Cadila completes dosing in Phase I clinical trial of ZyCoV-D expresspharma
August 06, 2020
Zydus Cadila announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe and well-tolerated in Phase I clinical trial. The company will now commence Phase II clinical trials from August 6, 2020.
AbCellera provides Covid-19 programme update with start of phase 3 clinical trials pharmaceutical-business-review
August 05, 2020
AbCellera announced that LY-CoV555, a human antibody discovered by AbCellera in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and co-developed with Eli Lilly and Company (Lilly) as ...
Vopec Pharma completes COVID-19 clinical trials of herbal formulation, Amrta Karuna expresspharma
August 04, 2020
Vopec Pharmaceuticals has announced that it has completed COVID-19 clinical trials on a herbal, Siddha formulation, Amrta Karuna.
J&J begins first trial of Covid-19 vaccine after positive preclinical data pharmaceutical-technology
August 03, 2020
Johnson & Johnson (J&J) has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers across the US and Belgium.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page